Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Case Report Volume 7 Issue 8

Posterior Reversible Encephalopathy Syndrome (PRES) in a Normotensive Pregnant Patient into Labour: A Case Report

Sofia Tsiapakidou1*, Eleftherios Klonos1, Stella Chondromatidou2, Grigoris F Grimbizis1and Theodoros D Theodoridis1

1Professor, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
2Department of Radiology, Papageorgiou General Hospital, Ring Road-Nea Efkarpia, Thessaloniki, Greece

*Corresponding Author: Sofia Tsiapakidou, Professor, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Received: December 08, 2022; Published: July 25, 2023

Abstract

Objective: To present a case of posterior reversible encephalopathy syndrome (PRES), a rare neurological disorder that can be presented, in association with preeclampsia, during pregnancy.

Case Report: This is the case of a 31-year-old nullipara at 40 weeks of pregnancy who presented with a sudden loss of consciousness accompanied by convulsions. She was normotensive throughout her pregnancy. An acute intracranial pathology, such as venous thrombosis, stroke, and cerebral hemorrhage was suspected. Neuroimaging revealed a parieto-occipital pattern reflecting vasogenic oedema and in correlation with postpartum seizures, PRES was diagnosed.

Conclusion: There is heterogeneity in how PRES can be presented, especially in the obstetric population, however, we emphasize the importance of early recognition and appropriate management in the obstetric population.

 Keywords: Encephalopathy; Labour; Posterior Reversible Encephalopathy Syndrome; Pregnancy; PRES

References

  1. Webster Katie., et al. “Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance”. BMJ (Clinical Research ed.) 366 (2019): l5119.
  2. Parasher Anant and Rajat Jhamb. “Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment”. Postgraduate Medical Journal1140 (2020): 623-628.
  3. Fugate Jennifer E and Alejandro A Rabinstein. “Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions”. The Lancet Neurology9 (2015): 914-925.
  4. Bartynski, W S. “Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features”.  American Journal of Neuroradiology 29.6 (2008): 1036-1042.
  5. Bartynski WS. “Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema”.  American Journal of Neuroradiology 29.6 (2008): 1043-1049.
  6. Amaral Lorena M., et al. “Pathophysiology and Current Clinical Management of Preeclampsia”. Current Hypertension Reports8 (2017): 61.
  7. Pedraza Rodrigo., et al. "Posterior reversible encephalopathy syndrome: a review". Critical Care Shock4 (2009): 135-143.
  8. Nielsen Lise Hald., et al. “Posterior reversible encephalopathy syndrome postpartum”. Clinical Case Reports4 (2015): 266-270.
  9. Ekawa Yuka., et al. “Reversible posterior leukoencephalopathy syndrome accompanying eclampsia: correct diagnosis using preoperative MRI”. The Tohoku Journal of Experimental Medicine1 (2012): 55-58.
  10. Fischer Marlene and Erich Schmutzhard. “Posterior reversible encephalopathy syndrome”. Journal of Neurology8 (2017): 1608-1616.
  11. Postma Ineke R., et al. “Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature”. Obstetrical and Gynecological Survey5 (2014): 287-300.

Citation

Citation: Sofia Tsiapakidou., et al. “Posterior Reversible Encephalopathy Syndrome (PRES) in a Normotensive Pregnant Patient into Labour: A Case Report”.Acta Scientific Medical Sciences 7.8 (2023): 187-190.

Copyright

Copyright: © 2023 Sofia Tsiapakidou., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US